MyFinsight
Home
Blog
About
Contact
Download
Download image
US
$20,816M
(1.50%↑ Y/Y)
Europe
$4,617M
(0.90%↑ Y/Y)
Rest Of World
$3,483M
(-1.22%↓ Y/Y)
Europe
$447M
(670.69%↑ Y/Y)
US
$60M
(-26.83%↓ Y/Y)
Rest Of World
$20M
(400.00%↑ Y/Y)
Product
$28,915M
(1.07%↑ Y/Y)
Royalty Contract And
Other
$527M
(265.97%↑ Y/Y)
Total revenues
$29,443M
(2.40%↑ Y/Y)
Operating income
$10,022M
(503.01%↑ Y/Y)
Other (income)
expense, net
$798M
(13200.00%↑ Y/Y)
Total costs and
expenses
$19,421M
(-28.31%↓ Y/Y)
Income before income
taxes
$9,796M
(1319.71%↑ Y/Y)
Interest expense
$1,024M
(4.81%↑ Y/Y)
Cost of goods sold
$6,234M
(-0.27%↓ Y/Y)
Research and development
expenses
$5,799M
(-1.83%↓ Y/Y)
Selling, general and
administrative expenses
$5,774M
(-5.20%↓ Y/Y)
Acquired in-process
research and development...
$1,024M
(-78.04%↓ Y/Y)
In-process research and
development impairments
$590M
(-85.89%↓ Y/Y)
Net income
$8,510M
(1672.92%↑ Y/Y)
Income tax (benefit)
expense
$1,286M
(509.48%↑ Y/Y)
Valuation allowance-US
-$538M
R&d tax credits
$143M
State taxes, net of
federal benefit
-$138M
Tax rate
differential-IE
-$118M
Foreign-derived intangible
income
$85M
Other
$9M
Tax rate
differential-Foreign Tax...
-$9M
Net income
attributable to gilead
$8,510M
(1672.92%↑ Y/Y)
Income tax expense at
u.s. federal...
$2,057M
Global intangible
low-taxed income
$85M
Acquired ipr&d and
related charges
$65M
Changes in unrecognized
tax benefits
$61M
Other-US
$27M
Other
$20M
U.s. taxation of
foreign branches
$9M
Other
$2M
Back
Back
Income Statement
source: myfinsight.com
Gilead_Sciences_Logo-svg
GILEAD SCIENCES, INC. (GILD)
Gilead_Sciences_Logo-svg
GILEAD SCIENCES, INC. (GILD)